Dose-Dependent Lowering of Mutant Huntingtin Using Antisense Oligonucleotides in Huntington Disease Patients

Author(s):
Roon-Mom, W.M.C. van; Roos, R.A.C.; Bot, S.T. de
Published
2018
Publication type
Article / Letter to editor
clinical trialHuntington diseasepatients
Date issued
2018-04-30
Language
English
Is part of
Nucleic Acid Therapeutics (2018), Vol. 28, no. 2, p. 59-62
hdl
1887/95522
doi
10.1089/nat.2018.0720